Zobrazeno 1 - 3
of 3
pro vyhledávání: '"IB Kononenko"'
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 9, Iss 3, Pp 326-335 (2016)
Development of anemia during chemotherapy or chemoradiotherapy of malignancies is a serious adverse event negatively affecting the quality of life and effectiveness of the treatment. In this regard, the leading consensus committees of NCCN, ESMO, ASC
Autor:
Blindar VN; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Dobrovolskaya MM; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Khagazheeva MN; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Zubrikhina GN; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Nesterova YA; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Davydova TV; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Lyubimova NV; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Kushlinskii NE; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Kononenko IB; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia., Snegovoy AV; FSBI «National Medical Research Center of Oncology N.N. Blokhin» Ministry of Health of Russia.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2021 Mar 30; Vol. 66 (3), pp. 147-153.
Autor:
Blindar VN; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Zubrikhina GN; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Davydova TV; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Somonova OV; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Elizarova AL; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Dobrovolskaya MM; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Kharitidi TY; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Lyubimova NV; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Kushlinsky NE; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Bobryshev AA; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Kononenko IB; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation., Snegovoy AV; Federal State Budgetary Institution «N.N. Blokhin Russian Cancer Research Center», under the Ministry of Health of the Russian Federation, 115478, Moscow, Russian Federation.
Publikováno v:
Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2019; Vol. 64 (4), pp. 210-215.